Partner in the Spotlight

PUK’s Paula Scurfield Reflects on the UK Research Conference 19-21 October 2021

pdmq_admin2022-01-16T14:04:24+00:00January 16th, 2022|News, Partner in the Spotlight|

The interests of neuroscientists and people with Parkinson’s (PwP) are inextricably linked in a symbiotic relationship. Increasingly, funding agencies are unwilling to grant research funds without evidence of PPI involvement. Clinicians readily admit that they gain insights and ideas for future research from their patients; we are then needed as trial participants. Yet when it comes to the easy-to-understand sharing of trial results, PwP are often excluded, the language of journals being mystifying to a non-scientist. Explaining the significance of [...]

MIMETAS hosts free, online 3D-cember meeting, December 3, 2021

pdmq_admin2021-11-18T11:51:48+00:00November 18th, 2021|News, Partner in the Spotlight|

MIMETAS recently reported that their 3D-cember event is coming right up on December 3rd, 2021. This online event is a celebration of 3D biology, focusing on new developments and applications in 3D cell culture. 3D tissue culture technologies and systems have come a long way over the last ten years. More and more scientists and physicians want to tap into the enormous potential of 3D tissue culture for drug development, patient care, and fundamental science. New biological applications and rapid [...]

ICM researchers will present PD-MitoQUANT research at AD/PD22

pdmq_admin2021-11-04T10:47:01+00:00November 4th, 2021|News, Partner in the Spotlight|

Dr Patrick Michel, ICM Noemi Asfogo, PhD candidate Dr Patrick Pierre Michel of the Institut du Cerveau – Paris Brain Institute (ICM) will present "MODELLING ALPHA-SYNUCLEIN AGGREGATION AND NEURODEGENERATION WITH FIBRIL SEEDS IN PRIMARY CULTURES OF DOPAMINERGIC NEURONS" and Noemi Asfogo, PhD candidate at the ICM will present "STUDYING MITOPHAGY IN NEURONAL MODELS OF ALPHA-SYNUCLEINOPATHY WITH THE FLUORESCENT MITOROSELLA REPORTER" at the upcoming AD/PD22: 16th International Conference on Alzheimer’s & Parkinson’s Diseases taking place online and in Barcelona, [...]

Warm welcome to Dr Isabela Aparicio of the RCSI

pdmq_admin2021-09-02T11:40:21+01:00September 2nd, 2021|News, Partner in the Spotlight|

Dr Isabela Aparicio PD-MitoQUANT welcomes Dr Isabela Aparicio, and her expertise! Based at the Royal College of Surgeons in Ireland- University of Medicine and Health Sciences, Dr Aparicio is originally from Rio de Janeiro, Brazil where she obtained a degree in Genetics and later was awarded an M.Sc. in Biophysics. After working as a Lecturer in Human Physiology and as a Qualified Patent Attorney, Dr Aparicio moved to Ireland on a doctoral fellowship at UCD, where was awarded [...]

The August 2021 PD-MitoQUANT newsletter is out!

pdmq_admin2021-08-12T10:44:03+01:00August 12th, 2021|News, Partner in the Spotlight|

Just out! Read the latest PD-MitoQUANT news in our just-published August 2021 newsletter. Coordinator Prof. Jochen Prehn provides an overview of the progress-to-date. Learn about three of our partners and their roles through our spotlight pieces on the University College London, the Centre National de la Recherche Scientifique and the Neuroscience Institute of the National Research Council (CNR). There's a dissemination round-up and much more! Download the August PD-MitoQUANT newsletter here.

Dr Sinéad O’Sullivan, DZNE presents at August 12th NeuroConnect meeting

pdmq_admin2021-08-09T12:20:59+01:00August 9th, 2021|News, Partner in the Spotlight|

Dr Sinéad O'Sullivan, Humboldt Fellow at the German Center for Neurodegenerative Diseases, the DZNE, will present PD-MitoQUANT findings and her research at the next NeuroConnect meeting, August 12th at 4:00 PM Irish Time. Dr O'Sullivan will present her research on alpha-synuclein induced mitochondrial dysfunction and the role of glial cells in Parkinson's disease. Sinéad's talk entitled 'Modelling alpha-synuclein pathology in vivo' will also include an overview of the pre-clinical models used in the lab: AAV human alpha-synuclein overexpression in the substantia [...]

CNRS Research Director Ronald Melki co-authors comprehensive Alpha-synuclein review in Nature

pdmq_admin2024-06-12T18:24:39+01:00August 5th, 2021|News, Partner in the Spotlight|

Prof Ronald Melki, CNRS Prof. Ronald Melki, Research Director at the CNRS co-authored with several Parkinson's research experts a recent review 'Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease'. The paper's authors are Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit [...]

Partners Parkinson’s UK join new ACT-PD (Accelerated Clinical Trials) initiative

pdmq_admin2021-07-09T07:07:59+01:00July 8th, 2021|News, Partner in the Spotlight|

Parkinson's UK Associate Director of Research Prof. David Dexter and PPI volunteer Paula Scurfield, together with some of the research staff at Parkinson's UK are involved in the new ACT-PD (Accelerated Clinical Trials) initiative. Funded by the Edmond J. Safra Foundation, ACT-PD is a 3-year programme that brings together national and international experts to develop a protocol and sustainable strategy for a multi-arm, multi-stage trial platform to investigate disease-modifying therapies in Parkinson’s disease. A Multi-Arm Multi-Stage (or MAMS) clinical trial is a [...]

MIMETAS opens new Phenotypic Screening Center in Leiden

pdmq_admin2021-06-01T07:55:37+01:00June 1st, 2021|News, Partner in the Spotlight|

PD-MitoQUANT partner MIMETAS, the global leader in human-relevant organ-on-a-chip models, opened their new Phenotypic Screening Center on May 27, 2021. The center, located in Leiden, NL facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques. MIMETAS OrganoPlate® technology used in the PD-MitoQUANT project offers the scalability and the throughput needed for drug discovery studies. “We are very proud to open up this new center,” said Jos [...]

Save the Date: Parkinson’s UK Excellence Network Conference, November 4th

pdmq_admin2021-05-31T09:41:47+01:00May 31st, 2021|News, Partner in the Spotlight|

Our partners at Parkinson's UK are organizing a 2021 Excellence Network Conference on November 4th, 2021. The online, one-day conference theme is 'Progression beyond the pandemic: what have we learned from coronavirus (COVID-19)?'. Together delegates will learn, share and discuss. The programme will focus on the future and share learning and experiences across the themes of: Restarting life after the pandemic Restarting services after the pandemic Technology Research Exercise The 8:00 AM-6:00 PM conference will assemble health and social care professionals, [...]